| About the author: |
M. Y. Zak, L. S. Kiro, I. V. Kushnirenko, T. M. Yablonska, I. A. Airapetian, M. V. Sverdlova |
| Heading |
CLINICAL MEDICINE |
| Type of article |
Scentific article |
| Annotation |
Non-alcoholic fatty liver disease in overweight and obese patients not only complicates the course of chronic somatic diseases, but also increases the risk of non-psychotic mental disorders in this category of patients (depression, anxiety disorders, panic attacks). The purpose of study was to determine the features of non-psychotic mental disorders in obese patients with non-alcoholic fatty liver disease. The Screening for Somatoform Symptoms–2 and the Taylor test were used to assess the presence of non-psychotic mental disorders. Somatized disorders in patients with non-alcoholic fatty liver disease on the background of obesity were recorded 9.6 times more often (D=0.579, p=0.0001<0.05) than in people with normal body mass index, mainly due to gastrointestinal and asthenic symptoms. Very high levels of anxiety were also recorded 2.5 times more often (p=0.007<0.05) than among patients in the control group. |
| Tags |
overweight, obesity, non-psychotic mental disorders, body mass index |
| Bibliography |
- Bischoff SC, Bernal W, Dasarathy S, Merli M, Plank LD, Schuütz T, et al. Praktychni nastanovy Yevropeiskoyi asotsiatsiyi klinichnoho kharchuvannia ta metabolizmu (ESPEN). Klinichne kharchuvannia pry zakhvoriuvanniakh pechinky. Suchasna hastroenterolohiya. 2021; 2(118): 28–40.doi: http://doi.org/10.30978/MG-2021-2-28 [in Ukrainian]
- Zhdan VM, Lebid VH, Ivanytskyi IV, Ishcheikina YuO, Boriak KhR. Otsinka hepatotoksychnoho efektu tryvaloho pryiomu statyniv za rezultatamy zsuvnokhvylovoyi elastometrii. Aktualni problemy suchasnoyi medytsyny: Visnyk Ukrainskoyi medychnoyi stomatolohichnoyi akademiyi. 2022; 1(77): 35–40. Doi: 10.31718/2077-1096.22.1.35 [in Ukrainian]
- Skrypnyk IM, Maslova HS, Shcherbak OV. Vplyv hipolipidemichnoyi terapii na stan systemy oksydu azotu u khvorykh na ishemichnu khvorobu sertsia v poiednanni z nealkoholnym steatohepatytom. Svit medytsyny ta biolohiyi. 2017: 4 (62):93–99. Doi: 10.26724/2079-8334-2017-4-62-93-99 [in Ukrainian]
- Albillos A, de Gottardi A, Rescigno M. The gut-liver axis in liver disease: Pathophysiological basis for therapy. J Hepatol. 2020 Mar; 72 (3):558–577. doi: 10.1016/j.jhep.2019.10.003. Epub 2019 Oct 14. PMID: 31622696.
- Dalle Grave R, El Ghoch M, Sartirana M, Calugi S. Cognitive Behavioral Therapy for Anorexia Nervosa: An Update. Curr Psychiatry Rep. 2016 Jan; 18 (1):2. doi: 10.1007/s11920-015-0643-4. PMID: 26689208.
- Hayes SC, Luoma JB, Bond FW, Masuda A, Lillis J. Acceptance and commitment therapy: model, processes and outcomes. Behav Res Ther. 2006 Jan; 44 (1):1–25. doi: 10.1016/j.brat.2005.06.006. PMID: 16300724.
- Jaurigue MM, Cappell MS. Therapy for alcoholic liver disease. World J Gastroenterol. 2016 Mar 7; 20 (9):2143–58. doi: 10.3748/wjg.v20.i9.2143. PMID: 24605013; PMCID: PMC3942819.
- Kalinowska S, Nitsch K, Duda P, Trześniowska-Drukała B, Samochowiec J. Depresja u dzieci i młodziezy-obraz kliniczny, etiologia, terapia. Ann Acad Med Stetin. 2018; 59 (1):32–6. Polish. PMID: 24734332 [in Polish]
- Kampman O, Viikki M, Leinonen E. Anxiety Disorders and Temperament-an Update Review. Curr Psychiatry Rep. 2017 May; 19 (5):27. doi: 10.1007/s11920-017-0779-5. PMID: 28417269.
- Małek A, Golińska P. Depression in Tourette syndrome. Psychiatr Pol. 2020 Feb 29; 54 (1):69–82. English, Polish. doi: 10.12740/PP/OnlineFirst/94471. Epub 2020 Feb 29. PMID: 32447357.
- Meuret AE, Tunnell N, Roque A. Anxiety Disorders and Medical Comorbidity: Treatment Implications. Adv Exp Med Biol. 2020; 1191: 237–261. doi: 10.1007/978-981-32-9705-0_15. PMID: 32002933.
|
| Publication of the article |
«World of Medicine and Biology» №2(80), 2022 year, 065-069 pages, index UDK 616.89-008:612.354-052]=111 |
| DOI |
10.26724/2079-8334-2022-2-80-65-69 |
